Tekla Capital Management LLC Aerie Pharmaceuticals Inc Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$13.12 - $20.9 $874,946 - $1.39 Million	-66,688 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $52,377 - $87,163	-1,808 Reduced 2.64%	66,688 $1.97 Million
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $1.08 Million - $1.46 Million	29,726 Added 76.67%	68,496 $3.25 Million
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $2.18 Million - $2.87 Million	38,770 New	38,770 $2.39 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.